GENETIC ASPECTS OF DEVELOPMENT OF ATRIAL FIBRILLATION
Abstract
Genetic aspects ofpathogeny of atrial fibrillation, as well as relation of the arrhythmia to canalopathies, long QT syndrome, short QT syndrome, Brugada syndrome, cardiomyopathies, and other conditions are considered.
About the Authors
M. A. Skuratova
Городская клиническая больница №1 им. Н.И.Пирогова
Russian Federation
Russian Federation
D. V. Duplyakov
Самарский областной клинический кардиологический диспансер, Самара
Russian Federation
Russian Federation
M. E. Zemlyanova
Самарский областной клинический кардиологический диспансер, Самара
Russian Federation
Russian Federation
References
1. Майк H.P. Long-Term outcome after stroke due to Atrial Fibrillation // Cerebrovask Dis 2003: 6 (Suppl.): 3-8.
2. Kopecky SL, Gersh BJ, McGoon MD et al. The natural history of lone atrial fibrillation. A population-based study over three decades // N Engl J Med 1987: 10: 317: 669674.
3. Marcus GM, Smith LM, Vittinghoff E et al. A first-degree family history in lone atrial fibrillation patients // Heart Rhythm. 2008: 5: 826-830.
4. Johnson JN, Tester DJ, Perry J et al. Prevalence of earlyonset atrial fibrillation in congenital long QT syndrome // Heart Rhythm 2008: 5: 704-709.
5. Chen LY, Herron KJ, Tai BC, Olson TM. Lone atrial fibrillation: influence of familial disease on gender predilection // J Cardiovasc Electrophysiol. 2008: 19: 802-806.
6. Bendahhou S., Marionneau C., Haurogne K. et al. In vitro molecular interactions and distribution of KCNE family with KCNQ1 in the human heart // Card Rec 2005: 67: 529-538.
7. Teng S., Ma L., Zhen Y. et al. Novel gene HKCNE4 slows the activation of the KCNQI channel // Biochem Biophys Res Commun 2003: 303: 808-813.
8. Abraham RL, Yang T, Blair M et al. Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation // J Mol Cell Cardiol. 2010: 48: 181-190.
9. Chen YN, Xu SJ, Bendahhou S et al. KCNQI gain -of-function mutation in family atrial fibrillation // Science 2003: 299: 251-254.
10. Sinner MF, Pfeufer A, Akyol M et al. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG) // Eur Heart J. 2008: 29: 907-914.
11. Benito B, Brugada R, Perich RM et al. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation // Heart Rhythm. 2008: 5: 1434-1440.
12. Tsuboi M, Antzelevitch C. Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7) // Heart Rhythm. 2006: 3: 328335.
13. Kirchhof P, Eckardt L, Franz MR et al. Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome // J Cardiovasc Electrophysiol. 2003: 14: 1027-1033.
14. Kusano KF, Taniyama M, Nakamura K et al. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds // JACC 2008: 51: 1169-1175.
15. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome // JACC 1992: 20: 1391-1396.
16. Villacorta H, Faig Torres RA et al. Sudden death in patient with right bundle branch block and persistent ST segment elevation // Arq Bras Cardiol. 1996: 66: 229-231.
17. Itoh H, Shimizu M, Ino H et al. Hokuriku Brugada Study Group. Arrhythmias in patients with Brugada-type electrocardiograph findings // Jpn Circ J 2001: 65: 483-486.
18. Perez Riera AR, Ferreira C, Dubner SJ et al. Brief review of the recently described short QT syndrome and other cardiac channelopathies // Ann Noninvasive Electrocardiol. 2005: 10: 371-377.
19. Brugada R, Hong K, Dumaine R et al. Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG // Circulation 2004: 109: 30-35.
20. Bellocq C, van Ginneken AC, Bezzina CR et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome // Circulation 2004: 109: 2394-2397.
21. Priori SG, Pandit SV, Rivolta I et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene // Circ Res. 2005: 96: 800-807.
22. Pizzale S, Gollob MH, Gow R, Birnie DH. Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation // J Cardiovasc Electrophysiol. 2008: 19: 1319-1321.
23. Burashnikov A, Antzelevitch C. New pharmacological strategies for the treatment of atrial fibrillation // Ann Noninvasive Electrocardiol. 2009: 14: 290-300.
24. Piatniski Chekler EL, Butera JA, Di L et al. Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents // Bioorg Med Chem Lett. 2009: 19: 45514554.
25. Damani SB, Topol EJ. Molecular genetics of atrial fibrillation // Genome Med. 2009: 1: 54-58.
26. Postma AV, van de Meerakker JB, Mathijssen IB et all. A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation //Circ Res. 2008: 102: 1433-1442.
27. Malhotra R, Mason PK. Lamin A/C deficiency as a cause of familial dilated cardiomyopathy // Curr Opin Cardiol. 2009: 24: 203-208.
28. Brauch KM, Chen LY, Olson TM. Comprehensive mutation scanning of LMNA in 268 patients with lone atrial fibrillation // Am J Cardiol. 2009: 103: 1426-1428.
29. Rai TS, Ahmad S, Ahluwalia TS et al. Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy // Mol Cell Biochem 2009: 331: 187-192.
30. Peters S. Long-term follow-up and risk assessment of arrhythmogenicrightventriculardysplasia/cardiomyopathy: personal experience from different primary and tertiary centers // J Cardiovasc Med. 2007: 8: 521-526.
31. Aranki S.F., Shaw D.P. Adams D.H. et al. Predictors of atrial fibrillation after coronary artery surgery // Circulation 1996: 94: 390-397.
32. Li D., Shinagawa K., Pang L. et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure // Circulation 2001: 104: 2608-2614.
33. Goette A., Staack T., Rocken C. et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation // JACC 2000: 35: 1669-1677.
Review
For citations:
Skuratova M.A., Duplyakov D.V., Zemlyanova M.E. GENETIC ASPECTS OF DEVELOPMENT OF ATRIAL FIBRILLATION. Journal of Arrhythmology. 2011;63(63):66-69. (In Russ.)
Views:
148
Email this article 